Bezornil® (Bezornyl®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspointment for rectal and external use
Composition:

On 1 g ointments:

active ingredients: artificial musk (muscon) - 0.009 g, pearls 0.0085 g, artificial bezoar 0.011 g, amber 0.0033 g, borneol 0.038 g, calamine (zinc carbonate) 0.108 g;

Excipients: lanolin - 0.04 g, vaseline - 0.7722 g, sodium hetoborate - 0.01 g.

Description:

Homogeneous ointment from light beige with a brownish or reddish hue to a dark beige with a brownish or reddish tint of color, with a specific smell with a predominant smell of borneol.

Pharmacotherapeutic group:Hemorrhoids treatment
ATX: & nbsp
  • Other preparations for the treatment of hemorrhoids and anal fissures for topical application
    • Pharmacodynamics:

    Complex preparation with local astringent, decongestant, antiseptic, analgesic, hemostatic effect.

    Pharmacological action is due to the combined action of biologically active substances that make up its composition (natural and identical natural synthetic components).

    Effective with respect to hemorrhoids observed pain, bleeding, as well as for cracks and itching in the anus.

    Pharmacokinetics:Due to low systemic absorption, no pharmacokinetics data are available.
    Indications:As part of complex therapy of chronic hemorrhoids and anal fissures.
    Contraindications:

    Hypersensitivity to the components of the drug, age to 18 years.

    Pregnancy and lactation:

    In pregnancy and during lactation apply only if the intended benefit to the mother exceeds the risk to the fetus and the baby.

    Dosing and Administration:

    Rectally.

    With internal hemorrhoids and fissures ointment is injected with a plastic tip into the anus 2 times a day and after each defecation.

    With external hemorrhoids and fissures Apply to the affected area 2 times a day and after each defecation. In addition, it is recommended to apply the ointment on a sterile napkin and place it on the affected area.

    The course of treatment is 14 days. The increase in the duration and conduct of repeated courses of treatment is determined by the attending physician.

    Side effects:Allergic reactions.
    Overdose:To date, no cases of drug overdose have been reported.
    Interaction:

    Not found.

    Special instructions:

    In the event that the existing symptoms of the disease do not decrease during treatment or if new unusual sensations appear, one should consult a doctor.

    Effect on the ability to drive transp. cf. and fur:The drug does not affect the ability to drive vehicles and work with moving machinery.
    Form release / dosage:Ointment for rectal and external use, 2 g and 10 g.
    Packaging:

    Ointment in tubes of 10 g.

    For 10 g of the drug is placed in a plastic tube with an inner layer of aluminum foil. The tube is sealed with aluminum foil and closed with a screw-on plastic cap. The tube together with the instructions for use and 4 plastic tips for intrarectal administration of the ointment, packed in a plastic bag, are placed in a cardboard box.

    Ointment in tubes of 2 g.

    2 g of the drug are placed in a plastic tube with an inner layer of aluminum foil, closed with a screw-on plastic cap. The tube together with the instruction for use is placed in a cardboard box.

    Storage conditions:

    In a dry, cool (up to 15 ° C), protected from light place.

    Keep out of the reach of children.

    Shelf life:3 years.
    Do not use after the expiry date printed on the package.
    Terms of leave from pharmacies:Without recipe
    Registration number:П N012011 / 01
    Date of registration:26.09.2011
    Expiration Date:Unlimited
    The owner of the registration certificate:Joint stock pharmaceutical company MAINLUN, 3rd pharmaceutical phaboic Joint stock pharmaceutical company MAINLUN, 3rd pharmaceutical phaboic China
    Manufacturer: & nbsp
    Representation: & nbspTao-Pharm 2009, LLCTao-Pharm 2009, LLCRussia
    Information update date: & nbsp21.01.2017
    Illustrated instructions
      Instructions
      Up